Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLOBAL LEADERS
NL-OMON44752Phase 3Active, not recruiting
- Sponsor
- ECRI
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor, aspirin, clopidogrel, bivalirudin in coronary arteriosclerosis, angina pectoris, acute coronary syndrome (ACS), sponsored by ECRI. Started Jul 2013; status: active, not recruiting.
02
Drugs
ticagreloraspirinclopidogrelbivalirudin
03
Conditions
coronary arteriosclerosisangina pectorisacute coronary syndrome (ACS)
Beyond the preview
Go deeper on NL-OMON44752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44752.